RASP | Jotup

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

Retrieved on:

Thursday, March 28, 2024

Biotechnology, Health, Pharmaceutical, Optical, Clinical Trials, RASP, Environment, Patient, NDA, University, Quality of life, Clinical trial, Therapy, University of California, Telecanthus, FDA, Food, DSM-IV codes, Pharmaceutical industry

Following discussions with the FDA, Aldeyra intends to initiate a dry eye chamber clinical trial in the first half of 2024.

Key Points:

Following discussions with the FDA, Aldeyra intends to initiate a dry eye chamber clinical trial in the first half of 2024.
In the proposed dry eye chamber trial, patients will be administered vehicle (the drug product without the active ingredient) before and during exposure to a dry eye chamber.
The design and statistical powering for the proposed trial are derived from four previously completed dry eye chamber clinical trials with reproxalap.
ET today, March 28, 2024, to discuss the clinical development plan for resubmission of the new drug application for reproxalap in dry eye disease.

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases

Retrieved on:

Thursday, January 4, 2024

ADX-629, administered twice daily over 90 days, has completed initial clinical testing in three adult patients in an investigator-sponsored clinical trial.

Key Points:

ADX-629, administered twice daily over 90 days, has completed initial clinical testing in three adult patients in an investigator-sponsored clinical trial.
Highlighting the advancement of the RASP platform and the selection of key clinical indications for future development, Aldeyra released a focused pipeline.
“With the success achieved in our ADX-629 program, which includes a number of positive, signal-finding clinical results, we are excited to advance our RASP modulator pipeline to systemic and retinal immune-mediated diseases, as well as metabolic diseases, exacerbated by RASP,” stated Dr. Brady.
“We anticipate 2024 to provide a variety of clinical-stage catalysts, as Aldeyra continues to progress its novel RASP platform.”

Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis

Retrieved on:

Tuesday, December 19, 2023

Biotechnology, Optical, Health, Clinical Trials, Atopic dermatitis, Principal, Body surface area, Therapy, Clinical trial, IGA, BAI, Patient, Safety, RASP, Pharmaceutical industry

Relative to baseline, over three months of treatment, improvement was observed in all patients.

Key Points:

Relative to baseline, over three months of treatment, improvement was observed in all patients.
EASI thresholds for 50% improvement (EASI‑50), 75% improvement (EASI-75), and 90% improvement (EASI-90) were met in four patients (50%), three patients (38%), and one patient (13%), respectively.
Statistical significance was achieved for improvement in depression (HAM-D, p=0.02) and numerical improvement was observed for improvement in anxiety (BAI, p=0.1).
ET today, December 19, 2023, to discuss the top-line results of the Phase 2 clinical trial of ADX-629 in atopic dermatitis.

Approov Identifies and Addresses Apple Watch Security Issues

Retrieved on:

Monday, December 18, 2023

The findings were released in today’s Approov blog “Approov Addresses Apple Watch Security Issues” at this link: https://approov.io/blog/apple-watch-security-issues

Key Points:

The findings were released in today’s Approov blog “Approov Addresses Apple Watch Security Issues” at this link: https://approov.io/blog/apple-watch-security-issues
Apple and MIT recently published a study indicating that 2.6 billion personal records were exposed through data breaches over the last two years.
Approov, a trailblazer in mobile app and API security, addresses this threat directly with Release 3.2.
“The newly released Apple Watch Series 9 and Ultra 2 will certainly be the gift of choice this Christmas.
Apple acknowledged the threat to all their devices, issuing a specific WatchOS Security briefing ( https://support.apple.com/en-mide/106360 ) on November 9 concerning a vulnerability in Apple Wallet on WatchOS.

Thales Completes the Acquisition of Imperva, Creating a Global Leader in Cybersecurity

Retrieved on:

Monday, December 4, 2023

This is a key milestone for Thales, creating a global leader in cybersecurity, with more than 5,800 cybersecurity experts across 68 countries and €2.4bn in cybersecurity revenue expected in 2024, including civil and defence activities, with double-digit growth expected thereafter.

Key Points:

This is a key milestone for Thales, creating a global leader in cybersecurity, with more than 5,800 cybersecurity experts across 68 countries and €2.4bn in cybersecurity revenue expected in 2024, including civil and defence activities, with double-digit growth expected thereafter.
This transaction will generate significant value creation for Thales’ shareholders in line with the targets communicated in July 2023, when announcing the acquisition.
“This acquisition marks a key step in Thales' ambition to become a global leader in cybersecurity, reinforcing its strength in data security and expanding into the buoyant application security market.
The acquisition of Imperva increases Thales’ digital security workforce in North America by almost a third.

Kiersten E. Todt Joins RunSafe Security's Board of Directors

Retrieved on:

Wednesday, November 15, 2023

Economics, Research, CISA, Policy, DARPA, Federation, Risk, Software, MTD, RASP, OS, News, Government, Todt, DevOps

MCLEAN, Va., Nov. 15, 2023 /PRNewswire/ -- RunSafe Security, the pioneer of a patented process to immunize software from cyberattacks without developer friction, today announced Kiersten E. Todt has joined its board of directors. With her background in cybersecurity and experience supporting the Federal Government on security initiatives to protect the United States from cyberattacks, Todt will add a vital layer of insights to RunSafe's mission. With her and the rest of the board's guidance, RunSafe will bolster its growing momentum to disrupt hacker economics and ensure critical infrastructure is resilient and operational.

Key Points:

MCLEAN, Va., Nov. 15, 2023 /PRNewswire/ -- RunSafe Security , the pioneer of a patented process to immunize software from cyberattacks without developer friction, today announced Kiersten E. Todt has joined its board of directors.
With her and the rest of the board's guidance, RunSafe will bolster its growing momentum to disrupt hacker economics and ensure critical infrastructure is resilient and operational.
"RunSafe is focused on preventing memory-based exploits at a time when the federal government has prioritized memory safety and resilience throughout critical infrastructure," said Kiersten Todt, CEO of Liberty Group Ventures and former Chief of Staff at CISA.
"With Kiersten joining our board, we expect to deepen our relationships across industry and align our support of policy efforts to ensure critical infrastructure is resilient and operational.

Appdome Partners with JetBrains TeamCity to Automate Delivery of Secure Mobile Apps

Retrieved on:

Thursday, November 2, 2023

JetBrains, SVP, Fraud, Consumer confidence index, App Store (iOS/iPadOS), DevOps, RASP, Manual, Kratos Defense & Security Solutions, Environment, Partnership, IOS, Mobile phone, Online shopping, Android

REDWOOD CITY, Calif., Nov. 2, 2023 /PRNewswire/ -- Appdome, the mobile app economy's one-stop shop for mobile app defense, today announced it has integrated its Cyber Defense Automation Platform with the CI/CD cloud-based service from JetBrains TeamCity allowing teams to automate the build, test and deployment of their mobile applications. JetBrains TeamCity is now part of the Appdome Dev2Cyber Agility Partner Initiative to advance the delivery of secure mobile apps globally.

Key Points:

JetBrains TeamCity is now part of the Appdome Dev2Cyber Agility Partner Initiative to advance the delivery of secure mobile apps globally.
The new Appdome-JetBrains TeamCity partnership solves mobile brands' need for technology platforms to automate the delivery of cyber defense in mobile apps and to keep pace with modern DevOps pipelines.
"JetBrains TeamCity is a key development platform for mobile apps, and developers using it need to be able to build security protections into their apps rapidly from within the platform," said Karen Hsu, SVP of Mobile DevOps and Security Solutions.
"This integration with JetBrains TeamCity enables brands and their development teams to meet growing demands from mobile users for stronger protection."

Data Theorem Mobile Protect Solution Earns Highest Standard of Online Safety and Privacy with COPPA Certification from kidSAFE

Retrieved on:

Tuesday, October 17, 2023

Data Theorem, Inc., a leading provider of modern application security , today announced its Mobile Protect solution has earned the highest standard of online safety and privacy by achieving Children’s Online Privacy Protection Act (COPPA) compliance certification from kidSAFE, an independent safety certification service and seal-of-approval program.

Key Points:

Data Theorem, Inc., a leading provider of modern application security , today announced its Mobile Protect solution has earned the highest standard of online safety and privacy by achieving Children’s Online Privacy Protection Act (COPPA) compliance certification from kidSAFE, an independent safety certification service and seal-of-approval program.
Data Theorem is the first application security leader to put its products through the rigorous safety and privacy COPPA certification process to better support its customers who build mobile applications designed for children.
As a result, Mobile Protect assures customers who develop children’s mobile apps that they are building safe apps that do not compromise children’s private data.
“Our partnership with Data Theorem continues to lay a foundation for improving standards focused on the safety, security and privacy of children’s data in the digital era.

Verimatrix Positioned as Leader in the 2023 SPARK Matrix™ for In-App Protection Report by Quadrant Knowledge Solutions

Retrieved on:

Monday, October 16, 2023

Ayush Patidar, Analyst at Quadrant Knowledge Solutions, states, “Verimatrix’s Extended Threat Defense Platform™ provides a holistic solution for protecting mobile apps, and providing detection and response capabilities to alert security teams of potential threats so they can take action before an attack occurs. Verimatrix's key differentiator is its zero code app telemetry that not only enables customers to quickly deploy app protection without the need to redevelop the app, but it allows for threat monitoring of any device -- including unmanaged consumer devices such as smartphones. This advanced technology empowers customers to receive EDR-like threat signals at the consumer device level, which is highly appealing to consumer-focused brands looking to extend their endpoint detection and response capabilities. Verimatrix has received strong ratings across technology excellence and customer impact and has been positioned as a leader in the SPARK Matrix: In-App Protection, Q2 2023.”

Key Points:

Verimatrix , (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it was named as a 2023 technology leader in the SPARK Matrix™: In-App Protection, by Quadrant Knowledge Solutions.
The Quadrant Knowledge Solutions SPARK Matrix™ includes a detailed analysis of the global market dynamics, vendor landscape, and competitive positioning.
"We are honored that this SPARK Matrix report recognizes Verimatrix as a leader in mobile app security.
To learn more about Verimatrix’s suite of cybersecurity solutions for apps and websites, visit: https://www.verimatrixcybersecurity.com .

Verimatrix Positioned as Leader in the 2023 SPARK Matrix™ for In-App Protection Report by Quadrant Knowledge Solutions

Retrieved on:

Monday, October 16, 2023

Knowledge, EDR, RASP, SPARK, Quadrant, SAN, Mobile app, API, Runtime application self-protection, Euronext Paris, Matrix, Mobile phone, Medical device, Verimatrix

Ayush Patidar, Analyst at Quadrant Knowledge Solutions, states, "Verimatrix's Extended Threat Defense Platform™ provides a holistic solution for protecting mobile apps, and providing detection and response capabilities to alert security teams of potential threats so they can take action before an attack occurs. Verimatrix's key differentiator is its zero code app telemetry that not only enables customers to quickly deploy app protection without the need to redevelop the app, but it allows for threat monitoring of any device -- including unmanaged consumer devices such as smartphones. This advanced technology empowers customers to receive EDR-like threat signals at the consumer device level, which is highly appealing to consumer-focused brands looking to extend their endpoint detection and response capabilities. Verimatrix has received strong ratings across technology excellence and customer impact and has been positioned as a leader in the SPARK Matrix: In-App Protection, Q2 2023."

Key Points:

The Quadrant Knowledge Solutions SPARK Matrix™ provides competitive analysis & ranking of the leading In-App Protection vendors.
SAN DIEGO, Oct. 16, 2023 /PRNewswire/ -- Verimatrix , (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it was named as a 2023 technology leader in the SPARK Matrix™: In-App Protection, by Quadrant Knowledge Solutions.
The Quadrant Knowledge Solutions SPARK Matrix™ includes a detailed analysis of the global market dynamics, vendor landscape, and competitive positioning.
Verimatrix has received strong ratings across technology excellence and customer impact and has been positioned as a leader in the SPARK Matrix: In-App Protection, Q2 2023 ."